3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
4
Gastrointestinal
2
Other hematologic neoplasm
1
Lymphoid
1
Genitourinary
1
Endocrine
1
Dermatologic
1
Conditions
Hematologic Neoplasms
1
Hematologic Diseases
1
Interventions
Cytarabine
898
Cyclophosphamide
892
fludarabine
516
venetoclax
473
fludarabine phosphate
464
Azacitidine
450
Rituximab
418
Methotrexate
414
Etoposide
319
Filgrastim
299
Busulfan
295
Dexamethasone
284
Vincristine
280
Daunorubicin
279
Peripheral Blood Stem Cell Transplantation
257
Whole-Body Irradiation
240
Mycophenolic Acid
231
Decitabine
227
Granulocyte Colony-Stimulating Factor
225
Tacrolimus
219
Idarubicin
202
Melphalan
201
Imatinib Mesylate
195
Cyclosporine
182
Doxorubicin
176
Radiotherapy
169
Prednisone
160
Mitoxantrone
160
Lenalidomide
159
Antilymphocyte Serum
154
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Complementary Therapies
×
Other hematologic neoplasm
×
Clear all
NCT07541326
2026-04-21
COMPLHEMATO
University Hospital, Limoges
Phase NA
Not yet recruiting
85 enrolled